A RubiconMD webinar. We’ll discuss why most modern patients with type 2 diabetes should be considered for GLP-1 therapy, and what to do when GLP-1 agents aren’t accessible.
We’ll explore ways to make social determinants of health (SDoH) screening and intervention sustainable in your practice.
What can we do to help folks with diabetes who don’t have access to the newest, most expensive medications?
Let’s dive into the data on tricky uses for GLP-1 agents, like in patients with gastroparesis, folks who’ve had bariatric surgery, and people at risk for pancreatitis.
Why does medicine in America cost so much? Lots of reasons (but mostly administrative costs, pharmacy costs, and high salaries). We’ll talk about it with third-year medical students.
Welcome, new Internal Medicine interns! We’ll quickly go through what’s expected from you for Journal Club this upcoming academic year. It’s gonna be a blast, I promise.
Jackie Catron, MPH, CHES - Kansas Department of Health and Environment
Christy Evers, DNP, APRN, CNM, CNEn - The University of Kansas School of Nursing
Amy Hagan, CHW Karen Morgan, BA, CHW
I’ll be moderating with Staci Stoltz, MSW
What do CHWs and Home Visitors need to know about diabetes in pregnancy?
What is gestational diabetes
Identifying risk factors
Early identification
Risk of developing type 2 diabetes after pregnancy
I’ll be moderating this meeting, and doing two sessions from 12:30-2:00 on pharmacist-physician collaboration around diabetes care with a special emphasis on gut health.
I’ll be talking about thyroid disease with members of the Kansas Academy of Family Physicians
Depending on feedback I get ahead of time, I think we’ll talk about:
Adrenal nodules
Adrenal insufficiency
Non-classic congenital adrenal hyperplasia
Assessment of adrenal function (that is, ruling out Cushing’s or adrenal insufficiency)
The focus will be very bedside-oriented, with just enough molecular biology and whatnot to make the clinical points make sense.
Learn how the prevention and management of diabetes not only improves quality of life for your employees, but saves your bottom line.
Diabetes and its complications are the first- or second-most expensive disease state in American health care. Many cases of diabetes are preventable, and proper management of diabetes can make a profound impact for those who are living with the condition.
Join us as we explore ways to detect pre-diabetes, prevent progression to “full blown” diabetes, and provide more effective treatments for people with diabetes.
Learning objectives for this program are:
Learn why diabetes should be top of mind for employers.
Discuss solutions to address the issue.
Share information on resources and local programs available to employers.
This program is being offering in partnership with the Health & Wellness Coalition of Wichita.
We’ll talk about:
Screening for binge-eating disorder
The Diabetes Prevention Program
Diabetes Self-Management Education and Support
Fiber supplementation
The NOVA food classification system
Intensive Behavioral Therapy
and other topics!
I’ll be talking with the KU-Wichita Internal Medicine residents about management of common inpatient endocrine emergencies like thyroid storm, adrenal crisis, and DKA.
The talk so nice, I’m doing it twice, this time geared toward family medicine docs and prenatal care.
Why does medicine in America cost so much? Lots of reasons (but mostly administrative costs, pharmacy costs, and high salaries). We’ll talk about it with third-year medical students.
The Diabetes Prevention Program reduces the risk of progressing from pre-diabetes to type 2 diabetes by ~58%. How does it stack up against other interventions like metformin, GLP-1 agents, and other lifestyle interventions?
We’re still working on this one, but I think we’ll probably cover treatment goals for elderly folks with diabetes, avoiding overtreatment/polypharmacy, and initiating insulin safely.
What makes American health care so expensive?
A patient arrives in clinic with a blood glucose of 600 mg/dl and mild ketonuria. What do you do? We’ll talk about it.
This is a redux of my talk at the KU Winter Symposium in 2021. I’ve updated the slideset to include more recent studies on dietary strategies that meet our highest standards of evidence. Examples are fiber supplementation, the Mediterranean diet for cardiovascular risk reduction, less-processed foods for weight reduction, and others.
Dr. Anne Meis and I will be talking about screening (including early screening), management, and post-partum management of gestational diabetes. We’ll include some data from a clinic where we’ve worked on quality improvement around gestational diabetes detection.
Even before the COVID-19 pandemic, social isolation was a growing public health problem. We will discuss strategies for mitigating isolation in the era of remote work.
Let’s talk about all the reasons we should be careful with newfangled hormonal therapies in menopause.
How can pharmacists and physicians more closely collaborate to provide high-quality diabetes care?
Your company might benefit from covering the Diabetes Prevention Program as a benefit. Valery Sokol and I will talk about it.
We live in a constant churn of diet information. What will we still believe in ten years? Let’s sort through the data to see what has staying power.
